PADCEV FDA approval date

The FDA approved PADCEV on 18 Dec 2019.

FDA approval date
18 Dec 2019

Drug identity has not yet been verified against registry records

Also recorded as ENFORTUMAB VEDOTIN-EJFV

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2019-12-18DayPADCEVFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761137", "applicant_as_listed_by_fda": "ASTELLAS", "brand_names": ["PADCEV"], "active_ingredients": ["ENFORTUMAB VEDOTIN-EJFV"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20191218", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026